About Us
Bicycle Therapeutics is developing a brand new class of small, chemically synthesized medicines called Bicycles.

To redefine what’s possible for people with cancer and other diseases.

Learn More

We were founded in 2009 to convert innovative Bicycles into transformative medicines for life-altering diseases.

Our proprietary phage display screening platform is based on novel science first conceived in the laboratory of Sir Greg Winter, winner of the Nobel Prize in Chemistry in 2018 for pioneering work in phage display. We are a transatlantic company, headquartered in the vibrant life science cluster of Cambridge, U.K., with key oncology functions and members of our leadership team located in the biotech hub of Boston, Mass., U.S.A.

Watch VideoWatch Video

We are experienced leaders who are driven by a common goal – to develop a novel class of therapies for diseases that are underserved by existing therapeutics.

Join Us